Sex-specific association of time-varying haemoglobin values with mortality in incident dialysis patients

Nephrology Dialysis Transplantation

Volumn 25, Issue 8, 2010, Pages 2715-2722

  Sturm, Gisela ^a   Lamina, Claudia ^a   Zitt, Emanuel ^b   Lhotta, Karl ^b,c   Lins, Friederike ^c   Freistätter, Otto ^c   Neyer, Ulrich ^b,c   Kronenberg, Florian ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Academic Teaching Hospital Feldkirch   (Austria)

^c Vorarlberg Institute for Vascular Investigation and Treatment VIVIT   (Austria)

Author keywords

end stage renal disease; haemoglobin; mortality; prospective observational study; time dependent Cox regression

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CALCIUM; FERRITIN; HEMOGLOBIN; PHOSPHORUS;

ADULT; AGED; ARTICLE; AUSTRIA; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN ANALYSIS; HUMAN; INFLAMMATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; METHODOLOGY; MODEL; MORTALITY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; RISK FACTOR; SEX DIFFERENCE; ANEMIA; BLOOD; CHRONIC DISEASE; COMPLICATION; KIDNEY DISEASES; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEXUAL DEVELOPMENT; SURVIVAL RATE; TIME;

ADULT; AGED; ANEMIA; CHRONIC DISEASE; COHORT STUDIES; FEMALE; HEMOGLOBINS; HUMANS; KIDNEY DISEASES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEX CHARACTERISTICS; SURVIVAL RATE; TIME FACTORS;

EID: 77954777791     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq101     Document Type: Article

References (38)

1. Ma JZ, Ebben J, Xia H, Collins AJ. Hematocrit level and associatedmor-tality in hemodialysis patients. J Am Soc Nephrol 1999; 10: 610-619 (Pubitemid 29117643)
2. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 1996; 28: 53-61
3. Levin A, Thompson CR, Ethier J et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 1999; 34: 125-134
4. Xia H, Ebben J, Ma JZ, Collins AJ. Hematocrit levels and hospitalization risks in hemodialysis patients. JAm Soc Nephrol 1999; 10: 1309-1316 (Pubitemid 29246997)
5. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 2007; 50: 471-530
6. Ofsthun N, Labrecque J, Lacson E, Keen M, Lazarus JM. The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients. Kidney Int 2003; 63: 1908-1914
7. Pisoni RL, Bragg-Gresham JL, Young EW et al. Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44: 94-111
8. Collins AJ, Ma JZ, Ebben J. Impact of hematocrit on morbidity and mortality. Semin Nephrol 2000; 20: 345-349
9. Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, Anderson JE. Association of anemia with outcomes in men with moderate and severe chronic kidney disease. Kidney Int 2006; 69: 560-564
10. Li S, Collins AJ. Association of hematocrit value with cardiovascular morbidity and mortality in incident hemodialysis patients. Kidney Int 2004; 65: 626-633
11. Besarab A, Bolton WK, Browne JK et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339: 584-590
12. Parfrey PS. Target hemoglobin level for EPO therapy in CKD. Am J Kidney Dis 2006; 47: 171-173
13. Strippoli GF, Craig JC. Hypothesis versus association: the optimal hemoglobin target debate. Am J Kidney Dis 2005; 46: 970-973
14. Volkova N, Arab L. Evidence-based systematic literature review of hemoglobin/hematocrit and all-cause mortality in dialysis patients. Am J Kidney Dis 2006; 47: 24-36
15. Drueke TB, Locatelli F, Clyne N et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355: 2071-2084
16. Foley RN, Parfrey PS, Morgan J et al. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. KidneyInt 2000; 58: 1325-1335
17. Furuland H, Linde T, Ahlmen J, Christensson A, Strombom U, Danielson BG. A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients. Nephrol Dial Transplant 2003; 18: 353-361
18. Levin A, Djurdjev O, Thompson C et al. Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD. Am J Kidney Dis 2005; 46: 799-811
19. Parfrey PS, Foley RN, Wittreich BH, Sullivan DJ, Zagari MJ, Frei D. Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. JAm Soc Nephrol 2005; 16: 2180-2189
20. Roger SD, McMahon LP, Clarkson A et al. Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trial. JAm Soc Nephrol 2004; 15: 148-156
21. RossertJ, Levin A, RogerSD etal. Effectofearly correction ofanemia on the progression of CKD. Am J Kidney Dis 2006; 47: 738-750
22. Singh AK, Szczech L, Tang KL et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085-2098
23. Regidor DL, Kopple JD, Kovesdy CP et al. Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol 2006; 17: 1181-1191
24. Berns JS, Elzein H, Lynn RI, Fishbane S, Meisels IS, Deoreo PB. Hemoglobin variability in epoetin-treated hemodialysis patients. Kid-neyInt 2003; 64: 1514-1521
25. Ebben JP, Gilbertson DT, Foley RN, Collins AJ. Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations. Clin JAm Soc Nephrol 2006; 1: 1205-1210
26. Fishbane S, Berns JS. Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin. KidneyInt 2005; 68: 1337-1343
27. Lacson EJr, Ofsthun N, Lazarus JM. Effect of variability in anemia management on hemoglobin outcomes in ESRD. Am J Kidney Dis 2003; 41: 111-124
28. Gilbertson DT, Ebben JP, Foley RN, Weinhandl ED, Bradbury BD, Collins AJ. Hemoglobin level variability: associations with mortality. Clin JAm Soc Nephrol 2008; 3: 133-138
29. Yang W, Israni RK, Brunelli SM, Joffe MM, Fishbane S, Feldman HI. Hemoglobin variability and mortality in ESRD. J Am Soc Nephrol 2007; 18: 3164-3170
30. Duncan JA, Levin A. Sex, haemoglobin and kidney disease: new perspectives. Eur J Clin Invest 2005; 35: 52-57
31. Therneau TM, Grambsch P. Modeling Survival Data: Extending the Cox Model. New York: Springer, 2008
32. Marx BD, Eilers PHC. Generalized linear regression on sampled signals and curves: A P-spline approach. Technometrics 1999; 41: 1-13
33. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2008;
34. Survival: Survival Analysis, Including Penalized Likelihood. R package version 2.34-1 Vienna, Austria: R Foundation for Statistical Computing, 2008
35. Schwaiger JP, Lamina C, Neyer U et al. Carotid plaques and their predictive value for cardiovascular disease and all-cause mortality in hemodialysis patients considering renal transplantation: a decade follow-up. Am J Kidney Dis 2006; 47: 888-897
36. Shemin D, Bostom AG, Laliberty P, Dworkin LD. Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis 2001; 38: 85-90
37. Humpeler E, Vogel S, Schobersberger W, Mairbaurl H. Red cell oxygen transport in man in relation to gender and age. Mech Ageing Dev 1989; 47: 229-239
38. Phrommintikul A, Haas SJ, Elsik M, Krum H. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 2007; 369: 381-388